Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Satoko Yamaoka & Hideki Ebihara. (2021) Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity. Virulence 12:1, pages 885-901.
Read now
Read now
Watee Seesuay, Surasak Jittavisutthikul, Nawannaporn Sae-lim, Nitat Sookrung, Yuwaporn Sakolvaree & Wanpen Chaicumpa. (2018) Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism. Emerging Microbes & Infections 7:1, pages 1-15.
Read now
Read now
Amy C Shurtleff, Tam L Nguyen, David A Kingery & Sina Bavari. (2012) Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design. Expert Opinion on Drug Discovery 7:10, pages 935-954.
Read now
Read now
Adrianna P.P. Zhang, Dafna M. Abelson, Zachary A. Bornholdt, Tong Liu, Virgil L. Woods, Jr & Erica Ollmann Saphire. (2012) The ebolavirus VP24 interferon antagonist. Virulence 3:5, pages 440-445.
Read now
Read now
Articles from other publishers (45)
Prashasti Sinha & Anil Kumar Yadav. (2023) Virtual Screening Based on Docking and Molecular Dynamics Simulations of Potential Ebola Receptor Inhibitors. ChemistrySelect 8:42.
Crossref
Crossref
Isra M. Alsaady, Leena H. Bajrai, Thamir A. Alandijany, Hattan S. Gattan, Mai M. El-Daly, Sarah A. Altwaim, Rahaf T. Alqawas, Vivek Dhar Dwivedi & Esam I. Azhar. (2023) Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library. Viruses 15:8, pages 1739.
Crossref
Crossref
Jing Yi Lai, Angela Corona, Chong Lee Ng, Enzo Tramontano, Yee Siew Choong & Theam Soon Lim. (2023) Naïve antibody library derived monoclonal antibody against VP35 of Ebola virus. International Journal of Biological Macromolecules 245, pages 125571.
Crossref
Crossref
Ratul Bhowmik, Ajay Manaithiya, Bharti Vyas, Ranajit Nath, Sara Rehman, Shubham Roy & Ratna Roy. (2022) Identification of potential inhibitor against Ebola virus VP35: insight into virtual screening, pharmacoinformatics profiling, and molecular dynamic studies. Structural Chemistry 33:3, pages 815-831.
Crossref
Crossref
Sayi’Mone Tati & Laleh Alisaraie. (2022) Recruitment of dynein and kinesin to viral particles. The FASEB Journal 36:5.
Crossref
Crossref
Angela Corona, Elisa Fanunza, Cristiano Salata, Melody Jane Morwitzer, Simona Distinto, Luca Zinzula, Cinzia Sanna, Aldo Frau, Gian Luca Daino, Marina Quartu, Orazio Taglialatela-Scafati, Daniela Rigano, StPatrick Reid, Alì Mirazimi & Enzo Tramontano. (2022) Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production. Antiviral Research 198, pages 105251.
Crossref
Crossref
Amanda Pinski, Courtney Woolsey, Allen Jankeel, Robert Cross, Christopher F. Basler, Thomas Geisbert & Ilhem Messaoudi. (2021) Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein. Journal of Virology 95:6.
Crossref
Crossref
Anna Laura Paulis, Angela Corona & Enzo Tramontano. 2021. Coronaviruses and other Novel Antiviral Targets. Coronaviruses and other Novel Antiviral Targets
153
174
.
Amanda N. Pinski & Ilhem Messaoudi. (2020) To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity. Microorganisms 8:10, pages 1473.
Crossref
Crossref
Tsuyoshi Miyake, Charlotte M. Farley, Benjamin E. Neubauer, Thomas P. Beddow, Thomas Hoenen & Daniel A. Engel. (2020) Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35. Journal of Virology 94:16.
Crossref
Crossref
Manuel Rojas, Diana M. Monsalve, Yovana Pacheco, Yeny Acosta-Ampudia, Carolina Ramírez-Santana, Aftab A. Ansari, M. Eric Gershwin & Juan-Manuel Anaya. (2020) Ebola virus disease: An emerging and re-emerging viral threat. Journal of Autoimmunity 106, pages 102375.
Crossref
Crossref
Elisa Fanunza, Aldo Frau, Angela Corona & Enzo Tramontano. (2019) Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets. Infectious Disorders - Drug Targets 19:4, pages 362-374.
Crossref
Crossref
Wenjie Wang, Chao Wu, Gaya K. Amarasinghe & Daisy W. Leung. (2019) Ebola Virus Replication Stands Out. Trends in Microbiology 27:7, pages 565-566.
Crossref
Crossref
Ting Shu, Tianyu Gan, Peng Bai, Xiaotong Wang, Qi Qian, Hui Zhou, Qi Cheng, Yang Qiu, Lei Yin, Jin Zhong & Xi Zhou. (2019) Ebola virus VP35 has novel NTPase and helicase-like activities. Nucleic Acids Research 47:11, pages 5837-5851.
Crossref
Crossref
Francesco Di Palma, Gian Luca Daino, Venkata Krishnan Ramaswamy, Angela Corona, Aldo Frau, Elisa Fanunza, Attilio V Vargiu, Enzo Tramontano & Paolo Ruggerone. (2019) Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition. Antiviral Chemistry and Chemotherapy 27, pages 204020661988922.
Crossref
Crossref
Gian Luca Daino, Aldo Frau, Cinzia Sanna, Daniela Rigano, Simona Distinto, Veronica Madau, Francesca Esposito, Elisa Fanunza, Giulia Bianco, Orazio Taglialatela-Scafati, Luca Zinzula, Elias Maccioni, Angela Corona & Enzo Tramontano. (2018) Identification of Myricetin as an Ebola Virus VP35–Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay. Biochemistry 57:44, pages 6367-6378.
Crossref
Crossref
Baptiste Martin & Étienne Decroly. (2018) Mécanismes d’échappement des filovirus à l’immunité innée. médecine/sciences 34:8-9, pages 671-677.
Crossref
Crossref
Robert W. Cross, Chad E. Mire, Heinz Feldmann & Thomas W. Geisbert. (2018) Post-exposure treatments for Ebola and Marburg virus infections. Nature Reviews Drug Discovery 17:6, pages 413-434.
Crossref
Crossref
Baocheng Liu, Shishang Dong, Guobang Li, Wenming Wang, Xiang Liu, Yantong Wang, Cheng Yang, Zihe Rao & Yu Guo. (2017) Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus. Journal of Virology 91:16.
Crossref
Crossref
Anagha S. Setlur, Sujay Y. Naik & Sinosh Skariyachan. (2016) Herbal Lead as Ideal Bioactive Compounds Against Probable Drug Targets of Ebola Virus in Comparison with Known Chemical Analogue: A Computational Drug Discovery Perspective. Interdisciplinary Sciences: Computational Life Sciences 9:2, pages 254-277.
Crossref
Crossref
Yan-Jun Zhang, Jing-Na Ding, Hui Zhong & Ju-Guang Han. (2017) Exploration micromechanism of VP35 IID interaction and recognition dsRNA: A molecular dynamics simulation. Proteins: Structure, Function, and Bioinformatics 85:6, pages 1008-1023.
Crossref
Crossref
Baptiste Martin, Bruno Canard & Etienne Decroly. (2017) Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle. Antiviral Research 141, pages 48-61.
Crossref
Crossref
Laura Baseler, Daniel S. Chertow, Karl M. Johnson, Heinz Feldmann & David M. Morens. (2017) The Pathogenesis of Ebola Virus Disease. Annual Review of Pathology: Mechanisms of Disease 12:1, pages 387-418.
Crossref
Crossref
Francesco Chiappelli, Allen M. Khakshooy, Andre Barkhordarian, Vandan R. Kasar, Melissa Nahcivan, Mia T. Nguyen, Jeong Min Hwang, Marena Martinez Kutschman, Angela Du & Nashwa Softo. 2017. Global Virology II - HIV and NeuroAIDS. Global Virology II - HIV and NeuroAIDS
751
777
.
Ji-Xia Ren, Rui-Tao Zhang, Hui Zhang, Xue-Song Cao, Li-Ke Liu & Yong Xie. (2016) Identification of novel VP35 inhibitors: Virtual screening driven new scaffolds. Biomedicine & Pharmacotherapy 84, pages 199-207.
Crossref
Crossref
Jason G. Glanzer, Brendan M. Byrne, Aaron M. McCoy, Ben J. James, Joshua D. Frank & Greg G. Oakley. (2016) In silico and in vitro methods to identify ebola virus VP35-dsRNA inhibitors. Bioorganic & Medicinal Chemistry 24:21, pages 5388-5392.
Crossref
Crossref
Megan R. Edwards, Gai Liu, Chad E. Mire, Suhas Sureshchandra, Priya Luthra, Benjamin Yen, Reed S. Shabman, Daisy W. Leung, Ilhem Messaoudi, Thomas W. Geisbert, Gaya K. Amarasinghe & Christopher F. Basler. (2016) Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins. Cell Reports 14:7, pages 1632-1640.
Crossref
Crossref
Prashant S. Kharkar, Ponnadurai Ramasami, Yee Siew Choong, Lydia Rhyman & Sona Warrier. (2016) Discovery of anti-Ebola drugs: a computational drug repositioning case study. RSC Advances 6:31, pages 26329-26340.
Crossref
Crossref
Zlatko Janeba. (2015) Development of Small-Molecule Antivirals for Ebola. Medicinal Research Reviews 35:6, pages 1175-1194.
Crossref
Crossref
Valeria Cannas, Gian Luca Daino, Angela Corona, Francesca Esposito & Enzo Tramontano. (2015) A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β. Journal of Infectious Diseases 212:suppl 2, pages S277-S281.
Crossref
Crossref
Joachim Denner. (2015) Treatment of Ebola virus infections with inhibitors of TLR4. Medical Hypotheses 85:3, pages 253-257.
Crossref
Crossref
Priya Luthra, David S. Jordan, Daisy W. Leung, Gaya K. Amarasinghe & Christopher F. Basler. (2015) Ebola Virus VP35 Interaction with Dynein LC8 Regulates Viral RNA Synthesis. Journal of Virology 89:9, pages 5148-5153.
Crossref
Crossref
Daisy W. Leung, Dominika Borek, Priya Luthra, Jennifer M. Binning, Manu Anantpadma, Gai Liu, Ian B. Harvey, Zhaoming Su, Ariel Endlich-Frazier, Juanli Pan, Reed S. Shabman, Wah Chiu, Robert A. Davey, Zbyszek Otwinowski, Christopher F. Basler & Gaya K. Amarasinghe. (2015) An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions. Cell Reports 11:3, pages 376-389.
Crossref
Crossref
Francesco Chiappelli, Andre Bakhordarian, April D Thames, Angela M Du, Allison L Jan, Melissa Nahcivan, Mia T Nguyen, Nateli Sama, Ercolano Manfrini, Francesco Piva, Rafael Rocha & Carl A Maida. (2015) Ebola: translational science considerations. Journal of Translational Medicine 13:1, pages 11.
Crossref
Crossref
Aaruni Saxena & Mauricio Ferri. 2018. Communicable Diseases of the Developing World. Communicable Diseases of the Developing World
1
36
.
Roosecelis Brasil Martines, Dianna L Ng, Patricia W Greer, Pierre E Rollin & Sherif R Zaki. (2014) Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. The Journal of Pathology 235:2, pages 153-174.
Crossref
Crossref
Wei Xu, Megan R. Edwards, Dominika M. Borek, Alicia R. Feagins, Anuradha Mittal, Joshua B. Alinger, Kayla N. Berry, Benjamin Yen, Jennifer Hamilton, Tom J. Brett, Rohit V. Pappu, Daisy W. Leung, Christopher F. Basler & Gaya K. Amarasinghe. (2014) Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1. Cell Host & Microbe 16:2, pages 187-200.
Crossref
Crossref
Qiao Xue, Qing‐Chuan Zheng, Ji‐Long Zhang, Ying‐Lu Cui & Hong‐Xing Zhang. (2014) Exploring the mechanism how Marburg virus VP35 recognizes and binds dsRNA by molecular dynamics simulations and free energy calculations. Biopolymers 101:8, pages 849-860.
Crossref
Crossref
Craig S. Brown, Michael S. Lee, Daisy W. Leung, Tianjiao Wang, Wei Xu, Priya Luthra, Manu Anantpadma, Reed S. Shabman, Lisa M. Melito, Karen S. MacMillan, Dominika M. Borek, Zbyszek Otwinowski, Parameshwaran Ramanan, Alisha J. Stubbs, Dayna S. Peterson, Jennifer M. Binning, Marco Tonelli, Mark A. Olson, Robert A. Davey, Joseph M. Ready, Christopher F. Basler & Gaya K. Amarasinghe. (2014) In Silico Derived Small Molecules Bind the Filovirus VP35 Protein and Inhibit Its Polymerase Cofactor Activity. Journal of Molecular Biology 426:10, pages 2045-2058.
Crossref
Crossref
Jennifer M. Binning, Tianjiao Wang, Priya Luthra, Reed S. Shabman, Dominika M. Borek, Gai Liu, Wei Xu, Daisy W. Leung, Christopher F. Basler & Gaya K. Amarasinghe. (2013) Development of RNA Aptamers Targeting Ebola Virus VP35. Biochemistry 52:47, pages 8406-8419.
Crossref
Crossref
Shridhar Bale, Jean-Philippe Julien, Zachary A. Bornholdt, Alexander S. Krois, Ian A. Wilson & Erica Ollmann Saphire. (2013) Ebolavirus VP35 Coats the Backbone of Double-Stranded RNA for Interferon Antagonism. Journal of Virology 87:18, pages 10385-10388.
Crossref
Crossref
Nicolas Martinez, Euripedes A. RibeiroJr.Jr., Cédric Leyrat, Nicolas Tarbouriech, Rob W. H. Ruigrok & Marc Jamin. (2013) Structure of the C-Terminal Domain of Lettuce Necrotic Yellows Virus Phosphoprotein. Journal of Virology 87:17, pages 9569-9578.
Crossref
Crossref
Jason Mercer & Urs F. Greber. (2013) Virus interactions with endocytic pathways in macrophages and dendritic cells. Trends in Microbiology 21:8, pages 380-388.
Crossref
Crossref
Parameshwaran RamananMegan R. Edwards, Reed S. Shabman, Daisy W. LeungAriel C. Endlich-Frazier, Dominika M. Borek, Zbyszek Otwinowski, Gai LiuJuyoung HuhChristopher F. Basler & Gaya K. Amarasinghe. (2012) Structural basis for Marburg virus VP35–mediated immune evasion mechanisms. Proceedings of the National Academy of Sciences 109:50, pages 20661-20666.
Crossref
Crossref
Luca Zinzula, Francesca Esposito, Daniela Pala & Enzo Tramontano. (2012) dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35. Antiviral Research 93:3, pages 354-363.
Crossref
Crossref